Finance

Beta
Lists
TRAW:NASDAQ
Traws Pharma Inc
$1.37
-7.43%
(-0.11) 1D
$1.41
+2.92% (+0.040)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TRAW...
Open
$1.45
High
$1.46
Low
$1.33
Mkt. cap
20.76M
Avg. vol.
4.40M
Volume
354.48K
52-wk high
$3.25
52-wk low
$1.00
EPS
-$1.56
Beta
1.45
Shares outstanding
15.15M
No. of employees
6
Open
$1.45
High
$1.46
Low
$1.33
Mkt. cap
20.76M
Avg. vol.
4.40M
Volume
354.48K
52-wk high
$3.25
52-wk low
$1.00
EPS
-$1.56
Beta
1.45
Shares outstanding
15.15M
No. of employees
6
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to TRAW in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for TRAW in the last 3 months.
Highest
Current $1.37
$8.00 (+483.94%)
Average
$8.00 (+483.94%)
Lowest
$8.00 (+483.94%)
News stories
From sources across the web
About Traws Pharma Inc
CEO-
Employees6
Founded1998
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.73M
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.29M
2.31M
5.04M
4.91M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.69M
1.74M
2.33M
2.03M
Operating expense
3.98M
4.06M
7.37M
6.95M
Total operating expenses
3.98M
4.06M
7.37M
6.95M
Operating income
-1.25M
-4.06M
-7.37M
-6.95M
Other non operating income
334.00K
93.00K
-553.00K
-161.00K
EBT including unusual items
-915.00K
-3.96M
-7.44M
-7.11M
EBT excluding unusual items
-915.00K
-3.96M
-7.44M
-7.11M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-915.00K
-3.96M
-7.44M
-7.11M
Net profit margin
-33.48%
-
-
-
Earnings per share
-
-
-0.55
-0.52
Interest and investment income
-
-
455.00K
-
Interest expense
-
-
-
-
Net interest expenses
-
-
455.00K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.25M
-4.04M
-7.32M
-6.90M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more